Company Filing History:
Years Active: 2011-2016
Title: Jingan Rui: Innovator in Cancer Research
Introduction
Jingan Rui is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on human cancer-related genes. With a total of 2 patents, his inventions are paving the way for new anti-cancer approaches and medicines.
Latest Patents
Jingan Rui's latest patents focus on the human cancer-related gene LAPTM4B and its encoded products. The inventions disclose various nucleotide sequences that are crucial for understanding cancer mechanisms. These sequences include SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, and SEQ ID No: 8. Additionally, the patents cover polynucleotides that encode specific protein sequences and DNA sequences with over 90% homology to the specified sequences. The implications of these inventions are profound, as they enable the development of new anti-cancer approaches and medicines that could significantly impact human society.
Career Highlights
Jingan Rui is affiliated with Peking University, where he continues to advance his research in cancer genetics. His work is recognized for its potential to transform cancer treatment and improve patient outcomes.
Collaborations
Jingan Rui collaborates with notable colleagues, including Rouli Zhou and Genze Shao. Their combined expertise enhances the research efforts in the field of cancer-related genetics.
Conclusion
Jingan Rui's innovative contributions to cancer research exemplify the importance of scientific advancements in combating diseases. His patents on human cancer-related genes are set to create a significant impact on medical science and society as a whole.